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Abstract 
 
Purpose 
To determine the inter-observer variation in delineating the coronary arteries as organs 
at risk (OARs) in breast cancer (BC) radiotherapy (RT) and how this variation affects the 
estimated coronary artery radiation dose.  
 
Method 
Delineation of the left main and the left anterior descending coronary artery (LMCA and 
LAD), and the right coronary artery (RCA), by using the heart atlas by Feng et al, was 
performed by three radiation oncologists in 32 women who had received adjuvant RT 
for BC. Centres of the arteries were calculated and distances between artery centres 
were measured and the artery radiation doses were estimated. The intraclass 
correlation coefficient (ICC) was used to quantify the variability in doses. 
 
Results 
Along the extent of RCA, the median distance between centres of arteries varied from 2 
to 9 mm with similar patterns over pairs of oncologists. For the LMCA-LAD the median 
distance varied from 1 to 4 mm. The estimated maximum radiation doses showed an ICC 
variation from 0.82 to 0.97. 
 
Conclusion 
The coronary arteries can be reliably identified and delineated as OARs in BC RT. The 
spatial variance is limited and the total variation in radiation dose is almost completely 
determined by the between patient variation. 
  
 
Introduction 
 
Breast cancer (BC) is the most common cancer form and cause of cancer death in women 
[1].  Adjuvant radiotherapy (RT) is standard treatment after breast conserving surgery 
(BCS) and in the case of lymph node metastases [2]. Large meta-analysis show 
significant benefits in terms of reducing local recurrences and breast cancer deaths [3, 
4]. In node-negative, and node-positive disease, respectively, an absolute 5-year risk 
reduction of 16.1%, and 30.1% for local recurrences, and an absolute risk reduction in 
15-year-breast cancer mortality of 5.1%, and 7.1% were shown, when RT was given 
after BCS. In patients undergoing mastectomy and axillary clearance and with lymph 
node metastasis, an absolute 5-year risk reduction of 17.1% for local recurrence, and 
5.4% for 15-year breast cancer mortality, was shown after RT to the chest wall and 
regional lymph nodes [3, 4].  
 
RT on the other hand increases the risk for heart disease due to incidental irradiation of 
the heart [5].  Trials have shown an increase in cardiac mortality and morbidity, and a 
relationship between higher absorbed radiation dose and a higher incidence of ischemic 
heart disease (IHD) [5-7]. In some studies, RT to the left breast is associated with higher 
risk of IHD than RT to the right breast, probably due to the localization of the heart [8, 
9]. Dosimetry studies have shown that the left anterior descending artery (LAD) receives 
the highest radiation doses [10, 11] and a higher incidence of coronary artery stenosis in 
the LAD has also been shown after RT of left-sided BC [12, 13].   
 
The relationship between absorbed radiation dose to the coronary arteries and IHD has 
raised the question whether coronary arteries should be regarded as separate organs at 
risk (OAR) in RT. Historically the heart has been regarded as an OAR. The radiation 
tolerance for the coronary arteries may however be different from other cardiac 
structures, and there are no current models for normal tissue complication probability 
(NTCP) concerning coronary artery toxicity [14]. The radiation volumes and doses to the 
heart have changed during the last decades due to the development of new radiation 
techniques but radiation doses to the most anterior part of the heart may still be high 
[11, 15]. 
 
A better understanding of radiation tolerance of the coronary arteries is important in 
order to form recommendations concerning dose constraints and consistent clinical 
guidelines. Modern three-dimensional (3 D) RT is based on the delineation of target 
volumes and OARs in the computerised tomography (CT) scan. Consistency in 
delineation is crucial in further development of NTCP models for coronary arteries and 
in the clinical practice to optimize the RT plan for each patient. Several studies have 
documented significant inter-observer variation in delineation of target volumes and 
OARs [16-18]. One previously published study on reproducibility of delineating 
coronary arteries showed a substantial inter-observer variation in estimated dose [19].  
The aim of the present study was to determine the degree of inter-observer variation in 
delineating the coronary arteries as OARs, and to assess the relationship between inter-
observer and inter-patient variability in estimated radiation doses to the coronary 
arteries.  
 
Patients and methods 
 
Patients 
 
The patients were defined from a larger cohort of irradiated women with BC who 
subsequently developed coronary artery stenosis requiring percutaneous coronary 
intervention. To identify the cohort, we selected women diagnosed with BC in three 
health care cancer regions of Sweden (Uppsala-Örebro, Stockholm and the Northern 
region) during the period 1992-2012 who had received adjuvant RT according to the 
Breast Cancer Quality of Care registers.  This BC cohort was then linked to the Swedish 
Coronary Angiography and Angioplasty Register, a part of the nationwide Swedish 
cardiac register SWEDEHEART [20].  For the present study all women treated at one of 
the radiotherapy departments, the Department of Oncology at the hospital of Gävle, 
were selected. Information concerning BC surgery, adjuvant endocrine therapy, 
chemotherapy, and tumour characteristics (invasive cancer or cancer in situ, size, grade, 
and nodal status) were obtained from the Breast cancer quality of care registers.  
 
Information regarding radiation targets, fractionation, total radiation dose, and CT slice 
thickness was retrieved from the radiotherapy charts. For dose estimation, the dose 
distribution from the treatment plans was used and all dose estimation was done in the 
Eclipse® treatment planning system (Varian Medical Systems Inc., Palo Alto, California 
USA) using the analytical anisotropic algorithm (AAA). Patients treated from 1997 to 
2005 were planned with the older system TMS® (Helax AB, Uppsala, Sweden) and for 
study purpose their treatment plans and CT scans were imported to the Eclipse system 
for delineation and dose calculation. The ethical committee (EPN) of Northern Sweden 
approved the study. 
 
 
 
 
Delineation 
 
The contouring of the coronary arteries was performed in the Eclipse dose planning 
system by three clinically experienced radiation oncologists from different centres in 
Sweden, independently of each other. The validated heart atlas by Feng et al was used as 
a guideline for the delineation of the coronary arteries and delineation was attempted in 
each CT slice [21]. The left main coronary artery (LMCA), the left anterior descending 
artery (LAD), and the right coronary artery (RCA) were delineated and the arteries were 
divided into segments corresponding to the proximal, mid, and distal parts of the 
arteries (Figure 1).  In the majority of the CT slices, the coronary arteries were visible 
but in difficult cases anatomical landmarks such as the left interventricular, left 
atrioventricular, and the right atrioventricular grooves were followed and the 
interpolation function in the target planning system was used. No extra margin was 
added to the contours. 
 Evaluation of inter-observer variation in spatial distance 
 
 
In order to evaluate the spatial variation, the x-, y-, and z-coordinates of the centre of the 
arteries LMCA-LAD and RCA were determined for each of the 96 combinations of the 32 
patients and the three radiation oncologists. The CT-slices determined the z-coordinate, 
whereas the x- and y-coordinates were determined using the centres of mass of the 
contoured area. For the sections of the arteries running in the same plane as the CT 
slices, the artery centre point was determined as a weighted average of the centres of 
mass of the contoured areas.  The weights were proportional to the contour areas. By 
applying this procedure sequences of n coordinates {(x1, y1, z1), (x2, y2, z2),…,(xn, yn, zn)}, 
were retrieved, one sequence for LMCA-LAD and one for RCA for each combination of 
woman and contouring radiation oncologist. The size of n will vary depending on artery, 
woman, the number of CT slices, and contouring radiation oncologist. Each sequence of 
points were joined by a straight line to form a three dimensional curve representing the 
midpoint of the artery. This is illustrated in figure 2 a, showing a CT-scan of a 
representative patient, in which the three different contouring radiation oncologists 
LMCA-LAD and RCA-curves are plotted.  
 
To measure the spatial difference in mm between the different curves, a three-step 
procedure was applied to each of the studied patients. At first the start- and end-points 
of the curves were determined (Figure 2 b). The choice of start point (one point for each 
of the three curves) was determined by comparing the results from three potential 
alternatives. Firstly, the point selected by oncologist A was used, denoted startA, and the 
distance to the points on the curves B and C with the shortest distance to startA , 
measured. For oncologist B and C similarly the closest points between the start points, 
startB and startC , were measured respectively, and the curves depicted by the two 
others. The final choice was the one that minimized the distance between the three 
points. The ending points were selected in a similar manner. Finally, the six curves were 
subdivided into 1001 equidistant points. The distance between these points were 
determined for each pair of radiation oncologists. The variation in distances between the 
32 patients was displayed by calculating the median, 25th and 75th percentiles. 
 
 
 
Evaluation of inter/intra-study subjects dose estimates 
 
LMCA-LAD and RCA were split in three parts (proximal, mid, and distal), according to 
Figure 1, which represents a schematic overview of the heart and the distribution of the 
coronary arteries. For each of the seven parts of the arteries (also referred to as 
segments) the variance in estimated doses was calculated, depending of the variance 
between radiation oncologists, the variance within study subjects, and the variance 
between the 32 study subjects. The intraclass correlation coefficient (ICC) was derived 
as a measurement of agreement between observers. A value of ICC=1.0 would indicate 
that the difference between the doses only would be due to the inter-patient variation 
and a value of ICC=0 would indicate that the difference would only be due to variation 
between the contouring radiation oncologists. The results are presented based on mean 
and maximum doses.  A subgroup consisting of 22 study subjects with CT slice thickness 
of 5 mm or less is presented separately.  
Results 
A total of 52 women who had received RT at the Department of Oncology of Gävle 
hospital, according to the Breast Cancer Quality of Care register, were identified in the 
main study cohort and this sub-cohort was used in the present study. Twenty out of 52 
women were further excluded, nine did not have a 3-D CT-based RT planning, six had 
missing RT plans, and finally five did not receive RT. The final cohort thus consisted of 
32 women who had received adjuvant RT due to breast cancer from 1997 to 2012. The 
patient characteristics are shown in Table 1. The age at diagnosis varied from 40 to 83 
years and the majority of the patients had screening detected, invasive cancers with a 
tumour size less than 20 mm, without lymph node metastases. The majority were 
treated with BCS and RT to the breast.  Out of these, 31 patients were treated with a 
fractionation of 2 Gy x 25, and one with a fractionation of 2.67 Gy x 16.  
The CT scans had a slice thickness varying from 2 to 15 mm. Twenty-two of the patients 
had CT slices of 5 mm or less, nine had CT slices of 10 mm, and one of 15 mm. The 
distance in mm between the centres of the delineated arteries in each CT slice following 
the arteries from the origin at the root of the aorta to the most distal segment is shown 
in Figure 3. The Result for the 22 patients with CT slices of 5 mm or less is presented in 
Figure 3, since CT slices of 5 mm or less can be considered as more applicable to modern 
RT techniques. The three different combinations, i.e: radiation oncologists A vs. B, A vs. 
C, and B vs. C, are shown for RCA and LMCA-LAD, respectively. For the RCA, the median 
distance between the centre points varies from 2 to 9 mm and the greatest differences 
were seen in the mid and distal parts of the artery. For the LMCA-LAD, the median 
distance varies from 1 to 4 mm with the greatest differences in the mid and distal LAD. 
The results were similar when patients with CT slices from 10-15 mm were included 
(data not shown). 
The variation of estimated mean and maximum doses to the arteries is shown in Table 2. 
The estimated radiation doses in right-sided and left -sided BC are shown separately due 
to the large differences in dose between right-sided and left-sided BC in some parts of 
the arteries. The doses in RCA were low with mean doses varying from 0.2 to 4.3 Gy, and 
maximum doses varying from 0.2 to 9.1 Gy, with the highest doses seen in the mid RCA 
of right-sided BC. In the LMCA-LAD the mean dose varied from 0.0-50.4 Gy, and the 
maximum dose varied from 0.1 to 51.3 Gy.  The highest doses were seen in the mid and 
distal LAD of left sided BC. The ICC varied from 0.73 to 0.99 indicating that most of the 
variation in estimated doses can be explained by differences between study subjects 
rather than the contouring radiation oncologists. The ICC is presented for the whole 
cohort and for the patients with CT slice thickness of 5 mm or less separately. 
 
Discussion 
In the present study of inter-observer variation in delineating the coronary arteries 
under conditions similar to the clinical routine, a good spatial agreement between three 
radiation oncologists was found, especially for the high-dose region of LAD. The median 
distance between the centres of the delineated arteries was 1-4 mm for LMCA-LAD. The 
same consistency was not shown for the RCA, in which the distance between the centres 
varied from 2 to 9 mm.  The estimated maximum doses to the RCA were in general low 
with max doses varying from 0.2-9.1 Gy with the highest doses seen in right-sided RT. In 
the LAD the estimated doses were uniformly high in mid and distal parts of the LAD in 
left-sided RT with maximum doses corresponding to the doses of the breast target of 
approximately 50 Gy.  
 
These results show that delineation of LMCA-LAD can be performed with an acceptable 
concordance between radiation oncologists, and that the high estimated doses seen in 
the mid and distal parts of the artery clearly show an urgent need of classifying of LMCA-
LAD as an OAR in left-sided RT. If the internal mammary chain will be included in the 
radiation field more frequently and if modern radiotherapy techniques like intensity-
modulated radiation therapy will be used in a wider extent, this might also influence the 
absorbed dose to the RCA and make delineating of this artery important as well. 
 
The evaluation of the estimated doses showed an ICC varying from 0.76 to 0.98 for 
LMCA-LAD and clearly demonstrates the reliability of delineating this artery between 
radiation oncologists. The high ICC indicate that in order to increase the power of in 
future dose response studies of cardiac side effects from RT, effort should be put on 
including more patients to the study rather than using several contouring radiation 
oncologists. For the RCA the ICC were slightly lower and varied from 0.73 to 0.92, 
suggesting that it might be of value to use several contouring radiation oncologists to 
allow for statistical methods taking measurement errors into account.  
 
The patients that were included in the study were treated from 1997 to 2012, and the CT 
scan series from the early treatments were performed with a slice thickness up to 15 
mm, which can be considered as a weakness.  However, analysis of patients with CT 
scans with slices of 5 mm or less, showed an ICC similar when compared to the whole 
cohort. The consistency for the delineation of LMCA-LAD would likely be even better if 
all patients had been planned using CT series with a currently used slice thickness of 2 
mm.  All the included patients were treated in the same department and this may be 
considered as a limitation of the study, since RT techniques may vary between 
institutions. 
 
Several studies have shown that high absorbed dose to the coronary arteries increases 
the risk of developing coronary stenosis leading, to IHD events as angina pectoris and 
myocardial infarction [5, 12, 13]. However, in a recent large population based study 
from Scandinavia, a statistical model including doses to the LAD in addition to the whole 
heart, failed to improve the association between radiation doses and the risk of coronary 
events [6]. In order to estimate and limit the dose to the coronary arteries, they need to 
be defined and delineated in RT planning. The previous studies concerning inter-
observer variation in delineation of the coronary arteries have focused on LAD and have 
shown a substantial variation in delineation and estimated dose to the artery [19, 22]. 
This has raised a question concerning the reliability of dose reporting in retrospective 
studies, and how estimated doses to LAD should be handled in clinical practice.  
 
In a study by Vennarini et al, only a third of the LAD was visible and the distal parts of 
LAD were the most difficult to visualize [22]. In a Danish study by Lorenzen et al, the 
inter-observer variation in delineating the LAD with or without guidelines was studied 
[19]. The guidelines used in that study were the validated CT atlas by Feng [21]. The 
study reported a reduced inter-observer variation concerning the length of the LAD but 
an increased variation in the left-right (L-R) and anterior-posterior (A-P) plane when the 
guidelines where used [19]. The estimated doses varied substantially and the 
consistency was not improved by using guidelines [19]. The design of the present study 
differed from the Danish study but the same CT atlas by Feng et al was used [19, 21]. The 
spatial variation in delineating the LAD was lower in the present study in comparison to 
the Danish study [19]. In contrast to the studies by Lorenzen and Vennarini and al [19, 
21], a decrease in consistency in the most distal parts of the LAD was not observed in the 
present study.  
 
Sufficient margins to cover the uncertainties of the delineation and the motion of the 
heart and respiration have to be taken in to account.  White et al have studied the impact 
of cardiac and respiratory movement on the accuracy of LAD delineation [23]. The 
conclusion of their study was that a margin of 2 mm in the A-P and L-R plane and of 4 
mm in the inferior-superior plane should be added on the contour delineated by the 
physician [23]. In a study by Dodge et al, using arteriograms, the diameter of LAD is 
estimated to 3,7±0,4 mm in the proximal and to 1,9±0,4 mm in the distal parts [24]. In 
terms of cardiac and respiratory motion, a diameter of 6 mm when delineating the LAD 
should be considered as sufficient based on the results of the present study and the 
study by White et al [23]. The use of intravenous contrast may further improve the 
accuracy of contouring the coronary arteries.  
 
The present study shows that it is feasible to delineate the LMCA-LAD in RT planning 
with acceptable inter-observer spatial variation and this is proposed to become clinical 
practice.  
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Table 1. Patient characteristics by laterality of breast cancer.  
 
 
 Right-sided BC 
(n=13) 
Left-sided BC 
(n=19) 
All BC 
(n=32) 
Year of breast cancer 
diagnosis, n (%) 
      
1997-2001 6 (46) 4 (21) 10 (31) 
2002-2007 4 (31) 7 (37) 11 (34) 
2008-2012 3 (23) 8 (42) 11 (34) 
Age at breast cancer diagnosis, 
n (%) 
      
40-49 yrs 2 (15) 2 (10) 4 (13) 
50-59 yrs 4 (31) 2 (10) 6 (19) 
60-69 yrs 6 (46) 6 (32) 12 (37) 
70-79 yrs 1 (8) 6 (32) 7 (22) 
80-83 yrs 0 (0) 3 (16) 3 (9) 
Mode of detection, n (%)       
Clinically detected 1 (8) 7 (37) 8 (25) 
Screening detected 12 (92) 12 (63) 24 (75) 
Cancer type, n (%)       
In situ 1 (8) 2 (10) 3 (9) 
Invasive 12 (92) 17 (90) 29 (91) 
Tumour size, n (%)       
≤20 mm 13 (100.0) 13 (68) 26 (81) 
21-50 mm 0 (0) 4 (21) 4 (13) 
>50 mm 0 (0) 2 (11) 2 (6) 
N-stage, n (%)       
N0 8 (62) 15 (79) 23 (72) 
N+ 2 (15) 1 (5) 3 (9) 
NX/Missing 3 (23) 3 (15) 6 (19) 
Grade, n (%)       
1 4 (31) 2 (11) 6 (19) 
2 7 (54) 12 (63) 19 (59) 
3 0 (0) 3 (16) 3 (9) 
Missing 2 (15) 2 (11) 4 (13) 
Type of surgery, n (%)       
BCS 13 (100.0) 14 (74) 27 (84) 
Mastectomy 0 (0) 5 (26) 5 (16) 
Endocrine therapy, n (%)       
Endocrine therapy 2 (15) 12 (63) 14 (44) 
No endocrine therapy 11 (85) 7 (37) 18 (56) 
Chemotherapy, n (%)       
Chemotherapy  1 (8) 4 (21) 5 (16) 
No Chemotherapy 12 (92) 15 (79) 27 (84) 
CT-scan slice thickness, n (%)       
2 mm 1 (8) 3 (16) 4 (13) 
2.5 mm 3 (23) 6 (32) 9 (28) 
5 mm 3 (23) 6 (32) 9 (28) 
10 mm 5 (38) 4 (21) 9 (28) 
15 mm 1 (8) 0 (0) 1 (3) 
Target, n (%)       
Breast 12 (92) 12 (63) 24 (75) 
Breast + reg LN 1 (8) 1 (5) 2 (6) 
Breast + reg LN + IMC 0 (0) 1 (5) 1 (3) 
Chest wall + reg LN 0 (0) 4 (21) 4 (13) 
Chest wall + reg LN + IMC 0 (0) 1 (5) 1 (3) 
Fractionation, n (%)       
2 Gy x 25 9 (69) 19 (100) 28 (88) 
2 Gy x 27 2 (15) 0 (0) 2 (6) 
2.67 Gy x 15 1 (8) 0 (0) 1 (3) 
2 Gy x 25 + boost 2 Gy x 8  1 (8) 0 (0) 1 (3) 
 
 
 
 
Breast cancer (BC), years (yrs), breast conserving surgery (BCS), regional lymph nodes 
i.e; axillar and supraclavicular lymph nodes (reg LN), internal mammary chain (IMC), 
Gray (Gy).  
 
  
Table 2. Range of minimum, median and maximum of mean and maximum radiation 
dose in Gray by laterality of breast cancer (BC) for the segments of the coronary arteries, 
with intraclass correlation coefficient (ICC) for the three different radiation oncologists: 
A, B, and C. The ICC for a subgroup consisting of patients with CT slice thickness of 5 mm 
or less is presented separately. The right coronary artery (RCA), the left main coronary 
artery (LMCA) and the left anterior descending artery (LAD) are shown. 
 
 
 
Mean doses Minimum 
of mean 
dose 
Median of 
mean dose 
Maximum 
of mean 
dose 
 All patients Restricted to 
patients with 
CT-slices of 
max 5 mm 
 Range for 
3 radiation 
oncologists 
Range for 
3 radiation 
oncologists 
Range for 
3 radiation 
oncologists 
 
ICC ICC 
(Left/right 
combined) 
ICC ICC 
(Left/right 
combined) 
Proximal RCA        
Right-sided BC 0.4 - 0.5 0.9 - 1.0 1.7 - 1.8 0.87 0.91 0.86 0.91 
Left-sided BC 0.5 - 0.8 1.2 - 1.4 2.5 - 2.6 0.92 0.92 
Mid RCA        
Right-sided BC 0.9 - 1.0 1.4 - 1.5 4.0 - 4.3 0.83 0.88 0.83 0.88 
Left-sided BC 0.2 - 0.3 0.8 - 0.9 1.7 - 2.0 0.86 0.86 
Distal RCA        
Right-sided BC 0.3 - 0.4 0.7 - 1.0 1.6 - 1.8 0.73 0.77 0.74 0.78 
Left-sided BC 0.2 - 0.3 0.6 - 0.6 1.4 - 1.7 0.78 0.78 
LMCA        
Right-sided BC 0.2 - 0.3 0.5 - 0.5 0.7 - 0.9 0.84 0.92 0.84 0.92 
Left-sided BC 0.7 - 0.7 1.0 - 1.3 1.9 - 2.3 0.83 0.83 
Proximal LAD        
Right-sided BC 0.1 - 0.2 0.3 - 0.3 0.5 - 0.5 0.88 0.94 0.88 0.94 
Left-sided BC 0.9 - 1.2 1.7 - 2.0 8.7 - 13.1 0.92 0.92 
Mid LAD        
Right-sided BC 0.0 - 0.1 0.1 - 0.1 0.3 - 0.4 0.97 0.84 0.97 0.84 
Left-sided BC 2.3 - 2.5 5.3 - 7.2 29.2 - 33.0 0.76 0.76 
Distal LAD        
Right-sided BC 0.0 - 0.0 0.0 - 0.1 0.3 - 0.3 0.98 0.99 0.98 0.99 
Left-sided BC 7.0 - 10.9 39.5 - 43.6 49.7 - 50.4 0.96 0.96 
 
 
 
 
Maximum Minimum Median of Maximum  All patients Restricted to 
doses 
 
 
of 
maximum 
dose 
maximum 
dose 
of 
maximum 
dose 
patients with 
CT-slices of 
max 5 mm 
 Range for 
3 radiation 
oncologists 
Range for 
3 radiation 
oncologists 
Range for 
3 radiation 
oncologists 
ICC ICC 
(Left/right 
combined) 
ICC ICC 
(Left/right 
combined) 
Proximal RCA        
Right-sided BC 0.6 - 0.9 1.3 - 1.6 2.4 - 2.7 0.75 0.84 0.75 0.84 
Left-sided BC 0.8 - 1.0 1.6 - 1.6 2.7 - 3.0 0.90 0.90 
Mid RCA        
Right-sided BC 1.3 - 1.5 2.1 - 2.3 5.5 - 9.1 0.61 0.75 0.61 0.75 
Left-sided BC 0.2 - 0.5 1.2 - 1.3 2.6 - 3.1 0.84 0.84 
Distal RCA        
Right-sided BC 0.5 - 0.8 1.2 - 1.8 2.8 - 3.3 0.80 0.83 0.80 0.83 
Left-sided BC 0.4 - 0.4 0.7 - 0.8 1.8 - 2.3 0.78 0.78 
LMCA        
Right-sided BC 0.2 - 0.4 0.6 - 0.6 1.0 - 1.1 0.88 0.91 0.88 0.90 
Left-sided BC 0.8 - 0.8 1.3 - 1.6 2.5 - 3.5 0.82 0.82 
Proximal LAD        
Right-sided BC 0.2 - 0.3 0.4 - 0.4 0.6 - 0.7 0.86 0.98 0.85 0.98 
Left-sided BC 1.1 - 1.8 2.2 - 2.8 22.1 - 24.6 0.97 0.97 
Mid LAD        
Right-sided BC 0.0 - 0.1 0.2 - 0.2 0.4 - 0.5 0.89 0.92 0.88 0.91 
Left-sided BC 3.6 - 4.8 16.6 - 35.7 45.4 - 48.5 0.84 0.84 
Distal LAD        
Right-sided BC 0.0 - 0.0 0.1 - 0.1 0.4 - 0.5 0.97 1.00 0.97 0.99 
Left-sided BC 16.7 - 33.6 47.1 - 47.5 51.0 - 51.3 0.85 0.85 
 
 
  
Figure 1 
The coronary arteries: the right coronary artery (RCA), the left main coronary artery (LMCA), the left anterior descending artery (LAD), 
and the left circumflex artery (LCX). RCA and LAD further subdivide into three segments: Proximal, Mid, and Distal. 
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Figure 2 
Figure 2 a: CT-scan of a representative patient, in which the three different radiation 
oncologists LMCA-LAD and RCA-curves are plotted.  
Figure 2 b: The definition of the start and end points of the curves. 
 
 
Figure 3 
 
The variation in distances between the centres of the arteries delineated by the three radiation oncologists for the 22 women with CT 
slice thickness of 5 mm or less. The 25th percentile, the median and the 75th percentile are shown. Breast cancer (BC), right coronary 
artery (RCA), LMCA (left main coronary artery), LAD (left ascending coronary artery). 
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